August 2014 FDA Recall Prosol by Baxter Healthcare Corp
D-1542-2014 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corp on August 4, 2014 for the product Prosol. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1542-2014

Reason for Recall
Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).
Initiated
08-04-2014
Reported
08-27-2014
Quantity
6,204 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corp
ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter Healthcare Corporation, Clinitec Nutrition Division, Deerfield, IL 60015 USA, Product Code 2B6186, NDC 0338-0499-06.

Batch or Lot Expiration Information

Lot# : P306225, Exp 08/14

Affected Packages Involved in this Recall